
Government Future Financing 2030 Program Signs a Cooperation Agreement with DIGITIZE for Investment and Technology Co.

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel



